Design, Synthesis, Characterization and Evaluation of Anticancer Activity of Substituted-4-(Substitutedphenylhydrazon o)-3,4-Dihydroquinolin-2-(1H)-One
The combined computational and biological data suggest that these hydrazinoquinoline derivatives, especially those with electron-withdrawing substituents, hold promise as lead structures for further development in liver cancer therapy targeting EGFR.
In this study, a new series of benzylthio-substituted benzimidazole-1,3,4-oxadiazole hybrids was designed, synthesized, and evaluated for their biological activity. The title compounds, 2-((2-(benzylthio)-1H-benzimidazol-1-yl)methyl)-5-aryl-1,3,4-oxadiazoles (1-4), were prepared through a multistep synthetic route star...
Mahmut Gozelle, Şevval Yaman, Züleyha Arslan et al.· Fabad journal of pharmaceuti...· 0 citations
New N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives were designed, synthesised, and evaluated as potential anticancer agents. Among the synthesised derivatives, compound 9c showed the highest potency against BCR-ABL1-positive K562 leukemia cells, with an IC50 of 0.26 ± 0.029 µM,...
Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al.· RSC Advances· 0 citations
A novel series of 2-hydrazono-5-acetyl-[1,3,4]thiadiazole and N'-ethylideneethanethiohydrazide derivatives tested as anticancer agents against a panel of cancer cell lines, and the mechanism of action of the most active compounds against liver cancer was explored through gene expression, DNA damage, and DNA fragmentati...
Ashraf A. Sediek, Eman Sabry, Huda F. Khalil et al.· Bioorganic chemistry (Print)· 0 citations
1,3,4-oxadiazole-2-thiol derivatives are established as promising dual-action therapeutic scaffolds for anticancer and antibacterial activities through computational and experimental approaches.
Ila M. Ram, Jay B. Maheta, Darshna K. Lakhnotra et al.· Future Medicinal Chemistry· 0 citations
These findings highlight these newly synthesized 2-thiohydantoin derivatives as promising scaffolds for the development of advanced therapeutic agents against prostate cancer.
T. Mahdi, D. Z. Mutlaq· Russian journal of bioorgani...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.